231. α1−アンチトリプシン欠乏症 Alpha-1-antitrypsin deficiency Clinical trials / Disease details

臨床試験数 : 93 / 薬物数 : 77 - (DrugBank : 8) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 36

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03945292 (ClinicalTrials.gov)	August 7, 2019	8/5/2019	Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)	A Placebo-Controlled, Multi-dose, Phase 2 Study to Determine the Safety, Tolerability and Pharmacody ...	Alpha 1-Antitrypsin Deficiency	Drug: Fazisiran Injection;Other: Placebo	Arrowhead Pharmaceuticals	NULL	Active, not recruiting	18 Years	75 Years	All	40	Phase 2	United States;Germany;Italy;Netherlands;Portugal;Spain;Canada;Ireland;Sweden

First Previous1Next Last